GREENLAND MINES LTD Notes Payable, Current
GREENLAND MINES LTD (GRML) had Notes Payable, Current of $1.77 million as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:NotesPayableCurrent · last filed 2026-08-14
- 2025-03-31: Notes Payable, Current $1.77M.
- 2024-12-31: Notes Payable, Current $240.75K.
- 2023-12-31: Notes Payable, Current $1.31M.
- 2022-09-12: Notes Payable, Current $1.31M.
| Period end | Notes Payable, Current |
|---|---|
| 2025-03-31 | $1.77M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $240.75K 10-K/A · filed 2026-08-14 |
| 2023-12-31 | $1.31M 10-K · filed 2025-03-31 |
| 2022-09-12 | $1.31M 10-K/A · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |